Is Pfizer About to Have Another Megablockbuster Drug in Its Lineup?

Is Pfizer About to Have Another Megablockbuster Drug in Its Lineup?

Source: 
Motley Fool
snippet: 
  • The FDA recently approved abrocitinib as a treatment for atopic dermatitis.
  • In the past, Pfizer has predicted the medicine could generate peak annual sales of around $3 billion.
  • However, abrocitinib's approval as a second-line treatment could limit its market opportunity.